Trade Summary

2 days ago, Bhatia Sangeeta N., serving as Dir at Vertex Pharmaceuticals Inc / Ma (VRTX), sold 318 shares at $423.73 per share, for a total transaction value of $134,746.00. Following this transaction, Bhatia Sangeeta N. now holds 4,924 shares of VRTX.

This sale represents a 6.00% decrease in Bhatia Sangeeta N.'s stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, May 4, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, May 5, 2026, 1 day after the trade was made.

Vertex Pharmaceuticals Inc / Ma operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.